Essentia Health

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease3 trials
• Familial hypercholesterolaemia3 trials
• Chronic kidney disease2 trials
• Stroke2 trials
• Type 2 diabetes2 trials
• ALS (motor neurone disease)1 trial
• Aortic aneurysm1 trial
• High blood pressure1 trial
• Type 1 diabetes1 trial

Phase

• Phase 33 trials
• Phase 42 trials
• Phase 2/31 trial

Status

• Active, not recruiting6 trials
• Recruiting3 trials
• Completed2 trials

Lead sponsor

• Duke University3 trials
• Abbott Medical Devices1 trial
• Brigham and Women's Hospital1 trial
• Essentia Health1 trial
• HealthPartners Institute1 trial
• and 4 more

Running trials

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Duke University· Source

  Contact: Martha Vanderlinde, BS

• Recruiting

  Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  NCT06906627· Duke University· Source

  Contact: Haley Messenger

• Active, not recruiting

  VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

  NCT06249165· Phase 4· Duke University· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

  NCT05390892· Phase 4· Brigham and Women's Hospital· Source

  Contact: Leah Tatelovich

• Active, not recruiting

  Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

  NCT05069558· Occlutech International AB· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Merit E. Cudkowicz, MD· Source

• Active, not recruiting

  Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

  NCT03728985· W.L.Gore & Associates· Source

• Active, not recruiting

  Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

  NCT03108456· Abbott Medical Devices· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Type 2 diabetes2 recruiting
• Coronary artery disease1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  Pediatric Blood Pressure Clinical Decision Support Tool (PedsBP CDS)

  NCT05126082· HealthPartners Institute· Source

• Completed

  Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

  NCT05238519· Phase 3· Essentia Health· Source